Insulin, Pharmacy Benefit Managers
High insulin prices spur a federal lawsuit against three pharmacy benefit managers
The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for diabetic patients. Three companies that process about 80% of prescriptions in the United States — Caremark,
Pharmacy benefit managers respond to FTC's lawsuit over insulin drug prices
CNBC's Eamon Javers joins 'The Exchange' to report the latest on the FTC's lawsuit against drug middlemen for allegedly inflating insulin prices.
Explainer: Why are US pharmacy benefit managers under fire?
The U.S. Federal Trade Commission said on Friday it was suing the country's three largest pharmacy benefit managers, accusing them of abusing their power and rigging the pharmaceutical supply chain to artificially inflate the cost of insulin.
Opinion
Commentary: Pharmacy benefit managers need tougher regulations
A group of Fortune 15 corporations have amassed enormous power as controversial middlemen between insurers, patients, drug makers and pharmacies.
Pharmacy benefit managers will have to pay Arkansas drugstores dispensing fees under new rule
The Arkansas Insurance Department will require pharmacy benefit managers (PBMs) to include dispensing fees in their reimbursements to pharmacies for prescription drugs, a legislative panel ruled Thursday.
Pharmacy benefit managers, version 2.0 (post J&J lawsuit)
2025 and 2026, they're right around the corner, and many employers are making changes now for 2025 or are anticipating changes for 2026, given a lot of the media attention around the lawsuits, prescription prices, the conversation around being a fiduciary, etc. It's really a pivotal time for pharmacy benefits.
FTC sues major pharmacy benefit managers over insulin prices
The agency brought action against Caremark, Express Scripts and Optum Rx on Friday, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the list price of life-saving insulin drugs.
New Idaho law to regulate pharmacy benefit managers. Will it reduce prescription drug costs?
In January, a new Idaho law will take effect requiring reform of business practices by pharmacy middlemen — in search of tamping down prescription drug costs. The new law targets pharmacy benefit managers,
Express Scripts sues FTC over a ‘biased’ report about pharmacy benefit managers
Express Scripts, one of the largest pharmacy benefit managers in the U.S., filed a lawsuit demanding that a recent FTC report on industry middlemen be vacated.
The Washington Post on MSN1d
FTC sues pharmacy insurance managers, alleging unfair drug prices
The Federal Trade Commission sued the three dominant pharmacy-benefit managers in the United States, alleging they inflated the cost of insulin by using their position as middlemen in the U.S.
JD Supra4d
Recent Legislative Developments Impacting Pharmacy Benefit Managers, Health Plans & More
As prescription drug costs remains a significant, and largely bipartisan, issue for state and federal legislators, we ...
Legislative panel backs emergency rule to boost pharmacy reimbursement
Rand told lawmakers that for about the past year, health insurance plans and pharmacy benefit managers have been reimbursing ...
Federal Trade Commission sues drug 'gatekeepers' over high insulin prices
The three price benefit managers jointly administer 80% of all prescriptions in the U.S., the FTC said in the lawsuit.